Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · IEX Real-Time Price · USD
0.717
-0.013 (-1.79%)
At close: Mar 28, 2024, 3:59 PM
0.753
+0.036 (4.99%)
After-hours: Mar 28, 2024, 6:52 PM EDT

Virax Biolabs Group Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019
Cash & Equivalents
9.350.020.020.02
Cash & Cash Equivalents
9.350.020.020.02
Cash Growth
42888.32%23.47%-22.06%-
Receivables
0000
Inventory
00.020.020
Other Current Assets
0.280.0100
Total Current Assets
9.630.050.040.02
Goodwill and Intangibles
0.18000
Total Long-Term Assets
0.18000
Total Assets
9.810.050.040.02
Accounts Payable
0.721.240.871.03
Deferred Revenue
0.04000
Current Debt
0.15000
Other Current Liabilities
0000.21
Total Current Liabilities
0.911.250.871.24
Total Liabilities
0.911.250.871.24
Total Debt
0.15000
Retained Earnings
-11.79-6.34-4.63-3.98
Comprehensive Income
-0-0-00
Shareholders' Equity
9.13-0.97-0.65-1.06
Net Cash / Debt
9.210.020.020.02
Net Cash / Debt Growth
42216.09%23.47%-22.06%-
Net Cash Per Share
8.660.020.070.22
Working Capital
8.73-1.2-0.83-1.22
Book Value Per Share
8.59-1.02-2.71-10.12
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).